First In Vivo Study of Laser-Driven Proton Radiation Shows Reduced Tissue Damage at Ultra-High Dose Rates
Researchers report the first in vivo investigation of normal tissue response to laser-driven proton irradiation, finding reduced tissue swelling compared to conventional X-ray irradiation. The study is part of broader research into the 'FLASH effect,' a phenomenon where ultra-high dose rate radiation spares healthy tissue more than tumor tissue, with protons and ions theorized to amplify this benefit. The findings could advance FLASH radiotherapy toward more precise cancer treatments that better protect surrounding healthy tissue.
A team of researchers has published the first in vivo study examining how laser-driven proton irradiation affects normal mammalian tissue, delivering 8 MeV protons at doses up to 50 Gy at 2 Gy per laser shot. The study found that laser-driven proton treatment resulted in less tissue swelling compared to conventional X-ray irradiation at standard dose rates, consistent with the so-called FLASH effect. RNA sequencing further revealed differential gene expression in immune and epidermal pathways following laser-driven proton irradiation at two different dose levels, offering early molecular clues about the underlying biology. Laser-driven proton accelerators are notable for their ability to deliver extremely high instantaneous dose rates in ultrashort pulses, a capability that distinguishes them from conventional accelerators. The FLASH effect — differential sparing of normal tissue relative to tumor control at ultra-high dose rates — has attracted significant scientific interest, though its precise mechanism remains poorly understood. This work represents a meaningful step toward harnessing laser-driven proton sources for therapeutic applications, though substantial translational research remains before clinical use.
What's missing
The study is a preprint posted on arXiv and has not yet undergone formal peer review. Key limitations include the absence of tumor model data (only normal tissue was studied), and no direct comparison to conventional proton FLASH sources. Long-term tissue outcomes beyond acute swelling are not reported.
What different sources said
- arXiv physicsCenter
Radiation damage to normal mammalian tissue in vivo with laser-driven protons at ultra-high instantaneous dose rate
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.